We investigated the effects of granulocyte colony-stimulating factor (G-CSF) on cytokine and cytokine receptor plasma levels and on the in vivo host response to Salmonella abortus equiendotoxin in healthy males. Twenty volunteers received 0.8 nglkg endotoxin and saline intravenously 1 week apart in randomized order. Twelve hours before both experiments, 10 of these subjects were pretreated with 300 p g G-CSF subcutaneously. G-CSF itself increased granulocyte and monocyte counts and the plasma levels of tumor necrosis factor-a (TNF-a), soluble TNF receptors (sTNF-R) p55, and p75 and interleukin-l receptor antagonist (IL-Ira). G-CSF did not influence plasma IL-1p and 11-6 levels. In the G-CSF-pretreated subjects endotoxin-induced surges in rec-EPTIC SHOCK DUE TO bacterial infection is a major cause of mortality following severe trauma and surgical procedures.' Endotoxins, cell-wall lipopolysaccharides &PS) of gram-negative bacteria, function as major pathophysiological factors in &he development of sepsis by stimulating macrophages to release cytokines such as interleukin-l/3 (IL-l,@, tumor necrosis factor-a (TNF-a), and interleukin-6 (K-6). These mediators play a crucial role in the deleterious events finally leading to multiple-organ failure and death.' Administration of endotoxin to volunteers is an accepted model for studying pathophysiological events during gram-negative bacterial infection in humans. In healthy subjects, even very low doses of endotoxin lead to a consistent stimulation of the host defense including increases in rectal temperature, leukocyte counts, and in the plasma levels of TNF-a, soluble TNF receptors (sTNF-R), IL-6, L 1 receptor antagonist (L-ha), corticotrophin, and cortisoI.'~h Strategies for counteracting the harmful effects of endotoxin in human sepsis have included the administration of antiendotoxin antibodies, anti-TNF antibodies, sTNF-R p75 and IL-lra, but none of these approaches has provided convincing clinical results."" Granulocyte colony-stimulating factor (G-CSF) is primarily known for its stimulatory effects on granulopoiesis.'* Elevated levels during infection and experimental endotoxemia in humans suggest that G-CSF may be involved in the primary host response.6,'3 In addition, some evidence renders G-CSF a candidate drug for the pre- 0006-4971/96/8703-0021$3.00/0 900 tal temperature and in the plasma levels of TNF-a plasma levels were about 50% increased, and surges in the plasma levels of both sTNF-Rs and IL-Ira were about twice as high as in the control group. Endotoxin-induced increases in IL-6, cortisol, and heart rate were not modified by G-CSF pretreatment. Endotoxin administration induced a transient 50% reduction in leukocyte counts in the G-CSF-pretreated subjects that was not seen in the control group. We conclude that a single standard dose of G-CSF increases the plasma levels of cytokines and cytokine receptors and considerably modifies the host response of healthy humans to a low dose of endotoxin.
tal temperature and in the plasma levels of TNF-a plasma levels were about 50% increased, and surges in the plasma levels of both sTNF-Rs and IL-Ira were about twice as high as in the control group. Endotoxin-induced increases in IL-6, cortisol, and heart rate were not modified by G-CSF pretreatment. Endotoxin administration induced a transient 50% reduction in leukocyte counts in the G-CSF-pretreated subjects that was not seen in the control group. We conclude that a single standard dose of G-CSF increases the plasma levels of cytokines and cytokine receptors and considerably modifies the host response of healthy humans to a low dose of endotoxin. 0 1996 by The American Society of Hematology, vention and treatment of gram-negative bacterial infection. G-CSF has been shown to be protective in different animal models of inflammation and infe~ti0n.l~"~ Furthermore, G-CSF pretreatment has been reported to reduce endotoxininduced TNF-a release and lethality in rodents.'" Ex vivo endotoxin-induced release of TNF-a was not changed in whole blood drawn from healthy humans treated with G-CSF 24 hours before. However, release capacity of IL-6, ILIra and sTNF-R p55, and p75 was enhanced."
In the present study we investigated the effects of G-CSF on plasma cytokine and cytokine receptor levels and on the primary host response to a low dose of endotoxin in healthy men. Host response parameters measured included rectal temperature, heart rate, blood pressure, leukocyte counts and the plasma levels of IL-lP, IL-lra, IL-6, TNF-a, sTNF-R p55, sTNF-R p75, and cortisol.
MATERIALS AND METHODS

Subjects.
Twenty healthy male volunteers took part in the present investigation after written informed consent had been obtained. The experimental protocol had received ethical approval. Before enrollment in the study, all potential participants were screened with a medical history, physical examination, laboratory investigations, electrocardiogram (EKG), and electroencephalogram to exclude individuals with acute or chronic disease.
Experimental procedures. In all subjects, the effects of 0.8 ng/ kg body weight of Salmonella abortus equi endotoxin on the primary host response were evaluated in a single-blind design. Endotoxin was available as a protein-free sterile solution; details of the preparation have been reported earlier.s In randomized order, endotoxin and 0.9% saline solution were given I week apart as a bolus intravenous injection at 0900 hours. Twelve hours before both the administration of endotoxin and placebo, I O subjects were pretreated with 300 pg of human recombinant G-CSF (Neupogen, purchased from Hoffmann LaRoche Ltd, Grenzach, Germany). All G-CSF vials used were from one batch. Contamination with endotoxin was excluded in one vial of this batch by the Limulus-lysate assay. Throughout every experimental session, one-lead EKG and rectal temperature (temperature monitor model 8055, S&W, Albertslund, Denmark) were continuously monitored. Blood was drawn through an indwelling venous catheter. Blood samples were stabilized with Na-EDTA (1 mg/mL) and aprotinin (300 KIU/mL), centrifuged and aliquoted, and plasma was frozen immediately to -20°C (for details see reference 5). Blood pressure was monitored with a Dinarnap Vital Daten Monitor 1846SX (Critikon, Norderstedt, Germany). Subjects remained in bed and were under continuous observation for 12 hours before and 24 hours following the administration of endotoxin and placebo, respectively. An experienced physician was on call during the whole experimental procedure. Emergency equipment was always available.
Assays. Blood cell counts were determined with a Coulter counter ST3 (Coulter Inc, Krefeld, Germany). IL-lp, TNF-a, sTNF-R p55, sTNF-R p75, and IL-6 were determined by enzyme-linked immunosorbent assays (Medgenix Diagnostics, Brussels, Belgium). For all these assays, the interassay and intraassay coefficients of variation were below 5% and 8%, respectively. Detection limits were 2 pglmL for IL-I@, 3 p@mL for TNF-a and IL-6, 50 pg/mL for sTNF-R p55, and 100 pg/mL for sTNF-R p75. To optimize the sensitivity of the TNF-a, assay we added an additional standard (4.3 pg/mL). The correlation of 24 consecutively sampled duplicate measurements in the range below 13 pg/mL was r = 0.99 (Pearsons's correlation; P < .Ol), demonstrating that in our hands the assay performs well, even in this low range of values. IL1-ra was measured by an enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN). The interassay and intraassay coefficients of variation were below 5%. The detection limit was 22 pg/mL. Plasma cortisol concentrations were measured by a coated tube radioimmunoassay (ICN Biomedicals, Carson, CA). Interassay and intraassay coefficients of variation were below 7%. The detection limit was 1.5 ng/ mL. For all assays, all samples of a particular subject were processed in the same kit.
Statistics. Data were processed with commercially available statistical software (SPSSPC+). Differences in the time courses of host response parameters were assessed by analysis of variance for repeated measures. Simple main effects were tested with unpaired Student's t-tests. As the major response to a low dose of endotoxin occurs within 5 hours after statistical analysis of the host response parameters was restricted to this time interval. Two-sided P values are reported, and P < .05 was considered significant. Values reported in the text, tables, and figures are means 2 standard error of mean (SEM).
RESULTS
Effects of G-CSF alone.
To evaluate the influence of G-CSF alone on indices of the host response, we compared the time courses of the respective parameters between G-CSFtreated and control subjects during those experimental sessions when the volunteers received placebo at 900 hours (Table 1, Fig 1) .
The controls and the G-CSF-pretreated subjects did not differ with respect to age (25.8 2 0.8 v 26.9 ? 1.4 years). Baseline (2100 hours) leukocyte (5. IL-l p plasma levels slightly above the detection limit could be detected in only four subjects of the control group and in two G-CSF-treated subjects. Therefore, analysis of variance (ANOVA) was not performed. None of the subjects reported any side effects; in particular, no musculoskeletal pain was reported after G-CSF administration. G-CSF did not influence serum alkaline phosphatase, gamma-glutamyl transferase, lactate dehydrogenase, or uric acid levels as assessed 36 hours after injection.
Influence of G-CSF on endotoxin-induced host response. Immediately before endotoxin administration, rectal temperature (36.5 ? 0.1 v 36.6 ? O.l"C), plasma IL-l@ (4.6 ? 4.5 v 0.4 2 0.3 pg/mL), IL-6 (7.6 ? 5.5 v 6.2 ? 3.5 pg/mL), and cortisol (135 2 17 v 129 ? 12 ng/mL) levels were similar in the controls and in the G-CSF-pretreated subjects, respectively. Consistent with the effects of G-CSF outlined above, G-CSF-pretreated subjects again showed higher ILIra (0. For (3.5 2 1.1 V 9.1 2 2.9 pg/mL, P < .09), sTNF-R p55 (1.4 -+ 0.1 v 2.1 2 0.2 ng/mL; P < .Ol), and sTNF-R p75 (3.5 -C 0.4 v 5.2 z 0.4; P < .01) plasma levels than the control group. Furthermore, leukocyte (4.9 t 0.3 v 25.6 2 1.6 X IO9& P < .Ol), neutrophil (2.9 2 0.3 v 23.0 2 1.0 X lo9/ POLLMACHER ET AL L, P < .Ol), and monocytes (0.2 2 0.0 v 0.9 0.1 X IO'/ L, P < .Ol) were higher before endotoxin administration.
To control for these effects of G-CSF pretreatment and for known circadian variations in plasma cortisol levels, rectal temperature and heart individual differences between the values from the endotoxin and the placebo trial were used to compare the effects of endotoxin in the two groups (Fig 2) .
ANOVA for repeated measures yielded significant time by condition interaction effects for endotoxin-induced changes in leukocyte counts (F [2, 36] in the control group endotoxin induced an increase in the leukocyte count without prior transient leukopenia, G-CSFpretreated subjects showed a rapid and substantial drop to about 50%, which was followed by an increase, but not to the preendotoxin level. As compared with the controls, the G-CSF-pretreated subjects showed higher endotoxin-induced increases in rectal temperature (2 and 3 hours postinjection), in TNF-a (1 and 2 hours postinjection), sTNF-R p55 (1 to 5 hours postinjection), sTNF-R p75 (1 to 5 hours postinjection), and in IL-lra ( 3 hours postinjection). Despite the significant time by condition interaction, IL-6 levels did not differ between the groups significantly at any of the time points tested. Endotoxin treatment increased heart rate Neither the G-CSF pretreated nor the control subjects showed detectable increases in the plasma IL-10 level after endotoxin. The frequency of endotoxin-induced side effects did not differ between the groups (short lasting: chills: three v three subjects, headache: three v five subjects, and body aches: three v one subject in the control group and the G-CSF-pretreated groups, respectively).
DISCUSSION
In the present investigation, a standard dose of G-CSF, in addition to its known enhancing effects on granulocyte and monocyte counts,".'' increased plasma cytokine and cytokine receptor levels in healthy subjects. Furthermore, certain in vivo host responses to endotoxin administered 12 hours after G-CSF were augmented.
Effects of G-CSF alone. G-CSF treatment increased the plasma levels of TNF-a, sTNF-R p55, sTNF-R p75, and ILIra. G-CSF did not influence rectal temperature, plasma ILlp, IL-6, and cortisol levels, but it did prevent the wellknown circadian drop in heart rate." G-CSF induced subtle increases in the plasma levels of TNF-a and IL-lra that were one to two orders of magnitude smaller than those observed in response to endotoxin, whereas the G-CSF-induced increases in the plasma levels of sTNF-R p55 and p75 reached about one and two thirds of the respective increases induced by endotoxin in the control group (compare Figs 1 and 2) . It is very unlikely that these effects were caused by a contamination of the G-CSF preparation with endotoxin, because endotoxin was not detected by the Limulus-lysate assay. Increased plasma cytokine and cytokine receptor levels after G-CSF treatment may be due to a release from monocytes or granulocytes that are also able to produce TNF-a, sTNF-Rs, and IL-lra.24-27 A study by Re et alzs that shows increased IL-Ira production of neutrophils after in vitro stimulation with G-CSF lends support to the idea of a direct treatment effect related to the immediate activation of neutrophils by G-CSF.29 However, Re et alZ8 also found IL-lra transcripts in unstimulated neutrophils. In addition, spontaneous release of sTNF-R p55 and sTNF-R p75 from neutrophils was documented by Lantz et al. 30 Therefore, G-CSFinduced increases in the plasma levels of cytokines and cytokine receptors may also be caused by spontaneous release from an increased number of either neutrophils or monocytes, or both.
Effects of G-CSF on the host response to endotoxin. In the present study, endotoxin administration to healthy subjects induced the well-known pattern of host response that includes increases in the plasma levels of cytokines, cytokine receptors and cortisol, rectal temperature, and heart This response pattern was considerably modified by G-CSF pretreatment. G-CSF-pretreated subjects showed larger endotoxin-induced surges in the plasma levels of TNF-a, sTNF-R p55, sTNF-R p75, and IL-lra. Endotoxin-induced increases in plasma IL-6, cortisol, and heart rate were not changed. The increased endotoxin-induced release of cytokines and cytokine receptors after G-CSF pretreatment may be related to the increased number of monocytes and granulocytes in the circulation. Increased sensitivity of neutrophils to endotoxin may also be involved, because it has recently been reported that G-CSF treatment upregulates the expression of CD14 on human ne~trophils.~' CD14 is one of the receptors for endotoxin complexed to endotoxin-binding proteir~,~' and transgenic mice expressing human CD14 are hypersensitive to endotoxin. 33 Our finding of an increased temperature response to endotoxin following G-CSF treatment could be due to the increased amounts of circulating TNF-a, known to be pyrog e n i~.~~.~~ The assay we used measures total TNF-a that includes TNF bound to sTNF-Rs. Based on in vitro studies it has been argued that the latter may not be biologically active.36 Because G-CSF alone increased the plasma levels of both sTNF-Rs, and the subsequent endotoxin-induced increase also was considerably augmented, one might expect to see a decreased biological activity of TNF-a. However, the modulation of TNF-a bioactivity by its own soluble receptors in vivo is complex. Soluble TNF-R p55 attenuated TNF-a bioactivity in nonhuman primates: but sTNF-R p75 increased bioactivity in mice.'7 Furthermore, it has been sug- tion.
The results we present here are in line with a study by Hartung et aI2' that reports increased ex vivo release of ILIra and sTNF-Rs from whole blood that was stimulated with endotoxin after G-CSF treatment in healthy volunteers. In contrast to our results, this study found no effect of G-CSF on endotoxin-induced TNF-a protein release and bioactivity. This discrepancy is probably due to the different experimental settings. Ex vivo stimulation does not stimulate the host response of the entire organism. In addition, low-dose endotoxemia induces a moderate and self-limited host response, whereas ex vivo models that use high amounts of endotoxin assess maximal cytokine release capacity. A study that investigated in parallel the endotoxin-induced in vivo host response and ex vivo cytokine release illustrates how different the results of the two experimental approaches can be. Cancer patients who were treated daily with Salmonella abortus equi endotoxin showed a progressive decline in the peak serum cytokine levels, including TNF-a and IL-6. In contrast, ex vivo stimulated mononuclear cells that were prepared from peripheral blood drawn before each endotoxin treatment showed a progressive increase in the release capacity for the same cytokines. '9 In the subjects without G-CSF pretreatment, the low dose of endotoxin we used did not induce the transient leukopenia reported in studies using Escherichia coli e n d o t o~i n .~,~~ However, injection of a higher amount of the same endotoxin preparation that we used in this study, caused a transient decline in leukocyte counts with its nadir 2 hours postinjection. 40 In the present study, G-CSF-treated subjects showed a profound transient drop in leukocyte counts 2 hours after endotoxin administration, thus suggesting that G-CSF pretreatment augments endotoxin-induced transient leukopenia. This finding is best explained by the well-known activating effects of G-CSF on neutrophils that includes its influence on adhesion molecules.2'~4"43 Again, G-CSF-induced upregulation of CD14 expression3' may be involved, because CD14 mediates the increasing effect of endotoxin on the adhesive activity of CR3 (CD1 1blCD18) on neutrophils. 44 Neutrophil adhesion, in turn, is a potent stimulus for the shedding of sTNF-Rs from neutrophils"' and, therefore, it may contribute to the increased endotoxin-induced surges in plasma levels of sTNF-Rs in G-CSF-treated subjects.
In summary, a single standard dose of G-CSF induced increases in plasma cytokine and cytokine receptor levels and considerably modified major aspects of the host response to a low dose of endotoxin administered 12 hours after G-CSF to healthy volunteers.
